Shivam Chemicals Ltd (544165)
🎯 Key Takeaways
- Shivam Chemicals Ltd is in a growth phase driven by operational expansion and strategic reinvestment, transitioning from a traditional trading model toward integrated manufacturing with a focus on backward integration and product diversification. The company has demonstrated strong financial momentum, reporting 30% revenue growth and 96% PAT increase in FY2025-26, while maintaining a conservative capital structure with low leverage (D/E 0.
- ⚠️ Overreliance on feed ingredient trading and manufacturing exposes the company to commodity price volatility and sector-specific demand cycles.
📖 The Story
Shivam Chemicals Ltd is in a growth phase driven by operational expansion and strategic reinvestment, transitioning from a traditional trading model toward integrated manufacturing with a focus on backward integration and product diversification. The company has demonstrated strong financial momentum, reporting 30% revenue growth and 96% PAT increase in FY2025-26, while maintaining a conservative capital structure with low leverage (D/E 0.40). Management is prioritizing sustainable growth through capacity expansion and supply chain optimization rather than dividend payouts.
📰 What's Happening
In the last quarter, Shivam Chemicals submitted its FY2025-26 Annual Report to BSE and scheduled its 16th AGM for 21 September 2026 to finalize audited financials and reappoint Director Shivam Sanjiv Vasant. The company announced the book closure for the AGM on 13 September 2026, requiring shareholders to be on record by then to vote. Board approval of the annual report and AGM agenda was confirmed on 27 August 2026. Management highlighted progress in expanding its feed ingredient portfolio and advancing backward integration via a new Quick Lime manufacturing unit in Rajasthan, alongside efforts to strengthen supply chain integration.
Source: Stock Announcements
🔮 Management Outlook & What's Next
Management has signaled a strategic focus on sustainable growth through product diversification, backward integration, and operational efficiency improvements. In the latest disclosures, the Board emphasized continued expansion of the feed ingredient portfolio and long-term value creation via reinvestment of earnings. No formal financial guidance was provided, but operational updates consistently tie growth initiatives to margin enhancement and supply chain resilience.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2024 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 12 | 17 | 17 | 17 |
| Reserves | 3 | 18 | 20 | 25 |
| Borrowings | 16 | 14 | 23 | 21 |
| Total Liabilities | 41 | 58 | 61 | 63 |
| Fixed Assets | 16 | 16 | 15 | 15 |
| Investments | 0 | 0 | 0 | 0 |
| Total Assets | 41 | 58 | 61 | 63 |
The balance sheet indicates a disciplined capital allocation strategy centered on reinvestment rather than leverage or shareholder returns. Equity and reserves have remained stable around ₹17-25 lakhs, while total assets have modestly increased from ₹58 lakhs to ₹63 lakhs over three years. Borrowings are minimal and stable at ₹14-23 lakhs, suggesting the company is funding growth internally. There is no evidence of aggressive capital raising or debt accumulation, reinforcing a conservative financial posture.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | -15 |
| Investing | -1 |
| Financing | +15 |
| Net Cash Flow | -0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 73.0% | 73.0% | 73.0% | 73.0% |
| FII | 0.0% | 0.0% | 1.5% | 1.5% |
| DII | 4.7% | 2.8% | 3.2% | 3.5% |
| Public | 17.7% | 19.6% | 16.9% | 17.0% |
| # Shareholders | 310 | 371 | 363 | 368 |
Promoter holding remains stable at 73% across all recent quarters, indicating confidence from management. Institutional interest has recently emerged, with FII ownership rising from 0% in Q3FY26 to 1.48% in Q4FY26 and Q1FY27, while DII holdings fluctuated between 2.83% and 4.72%. The number of public shareholders has slightly declined, but overall shareholder dispersion remains low. No significant selling by promoters or institutions is evident, and the shareholder base remains fragmented with 363-371 individuals.
⚖️ Peer Comparison — Trading
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| ADANIENT | 3.95 L Cr | 45.3 | 10.9% | 9.1% | 1.09 |
| PREMIERENE | 46,303 | 27.4 | 50.0% | 59.3% | 0.67 |
| AEGISLOG | 44,419 | 35.5 | 24.6% | 24.4% | 0.40 |
| REDINGTON | 28,003 | 16.5 | 18.4% | 14.8% | 0.26 |
| HONASA | 15,677 | 62.9 | 28.3% | 21.1% | 0.00 |
| 504346 | 11,409 | — | -24.9% | -47.5% | 0.73 |
| LLOYDSENT | 11,031 | 36.0 | 7.0% | 5.7% | 0.17 |
| SGMART | 10,131 | 81.4 | 11.2% | 7.8% | 0.14 |
| MMTC | 9,345 | 20.9 | 42.4% | 26.3% | 0.00 |
| EBGNG | 6,975 | 49.5 | 31.3% | 62.9% | 1.92 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Overreliance on feed ingredient trading and manufacturing exposes the company to commodity price volatility and sector-specific demand cycles. 2. The recent expansion into manufacturing (e.g., Quick Lime unit) introduces execution and operational risks in scaling new facilities. 3. Low institutional ownership and thin public float (16-19%) may lead to higher volatility and limited liquidity. 4. No dividend policy or return of cash may disappoint income-focused investors despite strong profitability.
📋 Recent Filings
-
🟡 Board Meeting 31 August 2026Shivam Chemicals announced the book closure for its 16th Annual General Meeting scheduled on 21 September 2026, with the register of members closed fr...
-
🔴 annual report 30 August 2026Shivam Chemicals Limited submitted its Annual Report 2025-26 to BSE on 30 August 2026, covering FY ending 31 March 2026. The report includes financial...
-
🔴 annual report 30 August 2026Shivam Chemicals Limited announced its 16th Annual General Meeting on 21 September 2026 at 11:00 a.m. at its Mumbai registered office. The meeting wil...
-
🟡 Board Meeting 27 August 2026Shivam Chemicals announced board approval of the 2025-26 Annual Report and AGM on September 21, 2026, with member records closed September 14-21. The ...
🧠 Analyst's Read
Shivam Chemicals is executing a clear growth strategy through reinvestment and backward integration, supported by robust top-line and bottom-line expansion. Investors should monitor progress of the new manufacturing initiatives and evolving institutional interest as indicators of medium-term momentum. The lack of dividends and stable promoter stake provide downside resilience, but scalability of new ventures remains a key watchpoint.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd